Approval · Notice of Compliance 8587 · 2007
PROGRAM SUSPENSION 7% (133MG/DOSE): Notice of Compliance 8587
Issued February 14, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8587
- Date
- February 14, 2007
- Company
- Novartis Animal Health Canada Inc.Mississauga, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing site
- Therapeutic class
- Antiparasitic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROGRAM SUSPENSION 7% (133MG/DOSE) | 02057832 | Cancelled Post Market |
Medicinal ingredients
- LUFENURON 133 MG per DOSE